Search
for
Sort by
Research 481–510 of 1000+
- Clinical aspects of the metabolic syndrome
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- The risk of coronary heart disease in men with androgenetic alopecia
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment